Literature DB >> 8117417

Direct intratumoral chemotherapy.

H Brincker1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8117417     DOI： 10.1016/1040-8428(93)90049-a

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  10 in total

1.  Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo.

Authors:  Rosana Hudej; Damijan Miklavcic; Maja Cemazar; Vesna Todorovic; Gregor Sersa; Alberta Bergamo; Gianni Sava; Anze Martincic; Janez Scancar; Bernhard K Keppler; Iztok Turel
Journal:  J Membr Biol       Date:  2014-06-24       Impact factor: 1.843

2.  Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems.

Authors:  Twan Lammers; Peter Peschke; Rainer Kühnlein; Vladimir Subr; Karel Ulbrich; Peter Huber; Wim Hennink; Gert Storm
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

3.  Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions.

Authors:  Dwaine F Emerich; Pamela Snodgrass; Denise Lafreniere; Reginald L Dean; Heather Salzberg; Joanne Marsh; Brigido Perdomo; Mahin Arastu; Shelley R Winn; Raymond T Bartus
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

4.  Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

Authors:  Ravi P Sahu; Jesus A Ocana; Kathleen A Harrison; Matheus Ferracini; Christopher E Touloukian; Mohammed Al-Hassani; Louis Sun; Mathew Loesch; Robert C Murphy; Sandra K Althouse; Susan M Perkins; Paul J Speicher; Douglas S Tyler; Raymond L Konger; Jeffrey B Travers
Journal:  Cancer Res       Date:  2014-10-10       Impact factor: 12.701

5.  Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells.

Authors:  Huan Xie; Beth Goins; Ande Bao; Zheng Jim Wang; William T Phillips
Journal:  Int J Nanomedicine       Date:  2012-05-03

6.  Albumin-Gold Nanorod Nanoplatform for Cell-Mediated Tumoritropic Delivery with Homogenous ChemoDrug Distribution and Enhanced Retention Ability.

Authors:  Hsien-Ting Chiu; Cheng-Kuan Su; Yuh-Chang Sun; Chi-Shiun Chiang; Yu-Fen Huang
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

7.  Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy.

Authors:  Baofa Yu; Yuanfei Lu; Feng Gao; Peng Jing; Han Wei; Peicheng Zhang; Guoliang Liu; Ning Ru; Guanghui Cui; Xinhai Xu; Chenglin Sun; Changjiang Guan; Yebing Che; Yingli Wu; Zhenlu Ma; Qiang Fu; Jian Liu; Huan-You Wang
Journal:  Lung Cancer (Auckl)       Date:  2015-01-07

8.  Intratumoral Administration of a Novel Cytotoxic Formulation with Strong Tissue Dispersive Properties Regresses Tumor Growth and Elicits Systemic Adaptive Immunity in In Vivo Models.

Authors:  Lewis H Bender; Franco Abbate; Ian B Walters
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

9.  Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Kaid Darwiche; Thomas Vogl; Eugene P Goldberg; Haidong Huang; Michael Simoff; Qiang Li; Robert Browning; Francis J Turner; Patrick Le Pivert; Dionysios Spyratos; Konstantinos Zarogoulidis; Seyhan I Celikoglu; Firuz Celikoglu; Johannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2013-07-18       Impact factor: 4.162

10.  Actively targeted in vivo multiplex detection of intrinsic cancer biomarkers using biocompatible SERS nanotags.

Authors:  U S Dinish; Ghayathri Balasundaram; Young-Tae Chang; Malini Olivo
Journal:  Sci Rep       Date:  2014-02-12       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.